S11 Ep5: Jhaveri on the INAVO120 Trial of Inavolisib/Palbociclib/Fulvestrant in PIK3CA -Mutant, HR+ Breast Cancer

from OncLive® On Air · host OncLive® On Air

Dr Jhaveri discusses the INAVO120 trial of inavolisib plus palbociclib and fulvestrant in PIK3CA-mutant, HR-positive metastatic breast cancer.

Episode metadata supplied by the publisher feed · Published Aug 22, 2024

Embed this episode

Attribution link and audio player

Ready to play

S11 Ep5: Jhaveri on the INAVO120 Trial of Inavolisib/Palbociclib/Fulvestrant in PIK3CA -Mutant, HR+ Breast Cancer

0:00 9:17

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 9 minutes long.

This episode was published on August 22, 2024.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!